Zobrazeno 1 - 6
of 6
pro vyhledávání: '"S D, Konduri"'
Autor:
N, Yanamandra, S D, Konduri, S, Mohanam, D H, Dinh, W C, Olivero, M, Gujrati, G L, Nicolson, M, Obeyeseke, J S, Rao
Publikováno v:
Clinicalexperimental metastasis. 18(7)
Urokinase-type plasminogen activator receptors (uPARs) play an important role in tumor invasion by localizing degradative enzymes at the invasive zone. Our previous studies with human glioblastoma cell line SNB19 expressing AS-uPAR stable tranfectant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::33ba71e08ca9b44e11d02fe7bdc6f9dc
https://pubmed.ncbi.nlm.nih.gov/11688967
https://pubmed.ncbi.nlm.nih.gov/11688967
Publikováno v:
Clinicalexperimental metastasis. 18(4)
Human tissue factor pathway inhibitor-2 (TFPI-2), also known as placental protein (PP5) and matrix-associated serine protease inhibitor (MSPI), is a 32-kDa extracellular matrix (ECM) protein consisting of three tandomly arranged Kunitz-type domains t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::149c4b10008d1c09d5359840550aea42
https://pubmed.ncbi.nlm.nih.gov/11448060
https://pubmed.ncbi.nlm.nih.gov/11448060
Publikováno v:
Clinicalexperimental metastasis. 18(3)
Human tissue factor pathway inhibitor-2 (TFPI-2) is a Kunitz-type serine protease inhibitor that inhibits plasmin, trypsin, chymotrypsin, cathepsin G and plasma kallikrein but not urokinase (uPA) or tissue-type plasminogen activator and thrombin. Ear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fcf38c09b71218b5631d8a110154383a
https://pubmed.ncbi.nlm.nih.gov/11315097
https://pubmed.ncbi.nlm.nih.gov/11315097
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(3)
Protease inhibitors regulate a variety of physiological and pathological processes including angiogenesis, embryo implantation, intravascular fibrinolysis, wound healing, and tumor invasion. Tissue factor pathway inhibitor (TFPI) 2 is a Mr 32,000 Kun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9e2950ab7bc2a45f61ec8a6d45adf0c0
https://pubmed.ncbi.nlm.nih.gov/11297250
https://pubmed.ncbi.nlm.nih.gov/11297250
Publikováno v:
International journal of oncology. 18(1)
Human tissue factor pathway inhibitor-2 (TFPI-2) is a 32-kDa serine protease inhibitor that inhibits plasmin, trypsin, chymotrypsin, cathepsin G, and plasma kallikrein but not urokinase and tissue-type plasminogen activators or thrombin. After discov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d952981d14925e1451315747c846453f
https://pubmed.ncbi.nlm.nih.gov/11115549
https://pubmed.ncbi.nlm.nih.gov/11115549
Autor:
C, Nirmala, S L, Jasti, R, Sawaya, A P, Kyritsis, S D, Konduri, F, Ali-Osman, J S, Rao, S, Mohanam
Publikováno v:
International journal of cancer. 88(5)
Radiation-induced damage to the central nervous system (CNS) is believed to target glial or endothelial cells or both, although the pathophysiology of the process is poorly understood. We therefore used a coculture system, in which glioblastoma SNB19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9818a0fd86248c552d2e6fd6ea13edb2
https://pubmed.ncbi.nlm.nih.gov/11072246
https://pubmed.ncbi.nlm.nih.gov/11072246